We are live on ! Find out more
RCMNY

Rubric Capital Management (New York) Portfolio holdings

AUM $9.44B
1-Year Est. Return 68.42%
This Fund
S&P 500
This Quarter Est. Return
-0.82%
1 Year Est. Return
+68.42%
3 Year Est. Return
+212.09%
5 Year Est. Return
+270.59%
10 Year Est. Return
AUM
$3.81B
AUM Growth
+$430M
Cap. Flow
+$532M
Cap. Flow %
13.96%
Top 10 Hldgs %
44.45%
Holding
75
New
7
Increased
31
Reduced
8
Closed
7

Top Buys

Rank Stock Value
1
ALIT icon
Alight
ALIT
+$70.1M
2
JAZZ icon
Jazz Pharmaceuticals
JAZZ
+$67.8M
3
MD icon
Pediatrix Medical
MD
+$59.9M
4
TDOC icon
Teladoc Health
TDOC
+$56.5M
5
CAR icon
Avis
CAR
+$53.3M

Sector Composition

Rank Sector Weight
1 Healthcare 49.51%
2 Technology 9.09%
3 Industrials 7.78%
4 Financials 7.37%
5 Utilities 6.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TEVA icon
1
Teva Pharmaceuticals
TEVA
$41.3B
$281M 7.35%
17,261,741
-407,847
-2% -$6.28M
ROIV icon
2
Roivant Sciences
ROIV
$26B
$243M 6.37%
23,000,000
+3,000,000
+15% +$32.9M
VTRS icon
3
Viatris
VTRS
$19.4B
$214M 5.61%
20,144,365
+1,702,272
+9% +$18.8M
GLNG icon
4
Golar LNG
GLNG
$5.11B
$205M 5.37%
6,535,062
+28,305
+0.4% +$748K
BGC icon
5
BGC Group
BGC
$4.94B
$158M 4.13%
19,000,000
FLR icon
6
Fluor
FLR
$7.54B
$140M 3.67%
3,214,521
+614,521
+24% +$25.6M
COOP
7
DELISTED
Mr. Cooper
COOP
$123M 3.23%
1,518,773
QDEL icon
8
QuidelOrtho
QDEL
$817M
$121M 3.18%
3,645,590
+1,245,590
+52% +$51M
VST icon
9
Vistra
VST
$45.8B
$114M 2.99%
1,327,106
+113,108
+9% +$9.47M
LBTYA icon
10
Liberty Global Class A
LBTYA
$3.65B
$96.3M 2.53%
5,526,107
+1,680,756
+44% +$28.4M
HRTX icon
11
Heron Therapeutics
HRTX
$92.8M
$93.5M 2.45%
26,713,503
ARQT icon
12
Arcutis Biotherapeutics
ARQT
$3.29B
$91.3M 2.39%
9,816,672
+2,306,672
+31% +$20.9M
RNW icon
13
ReNew
RNW
$2.24B
$84.3M 2.21%
13,506,102
+1,794,402
+15% +$10.8M
COLL icon
14
Collegium Pharmaceutical
COLL
$950M
$75.1M 1.97%
2,333,500
+499,473
+27% +$17.3M
CAR icon
15
Avis
CAR
$5.03B
$72.1M 1.89%
690,273
+475,181
+221% +$53.3M
EXTR icon
16
Extreme Networks
EXTR
$3.21B
$70.7M 1.85%
5,254,744
+1,804,744
+52% +$20.7M
CSTM icon
17
Constellium
CSTM
$3.93B
$69M 1.81%
3,662,895
+32,548
+0.9% +$677K
AMRX icon
18
Amneal Pharmaceuticals
AMRX
$5.81B
$68.1M 1.79%
10,721,778
+1,179,830
+12% +$7.49M
MATV icon
19
Mativ Holdings
MATV
$664M
$67.8M 1.78%
4,000,000
JAZZ icon
20
Jazz Pharmaceuticals
JAZZ
$16.7B
$65.8M 1.73%
+616,617
New +$67.8M
PTVE
21
DELISTED
Pactiv Evergreen Inc. Common stock
PTVE
$64.8M 1.7%
5,726,583
+185,190
+3% +$2.46M
DOLE icon
22
Dole
DOLE
$1.32B
$62.9M 1.65%
5,141,388
LBTYK icon
23
Liberty Global Class C
LBTYK
$3.56B
$62.7M 1.64%
3,511,004
+1,617,711
+85% +$28.2M
ALIT icon
24
Alight
ALIT
$413M
$62.2M 1.63%
+421,153
New +$70.1M
MD icon
25
Pediatrix Medical
MD
$2.2B
$61.5M 1.61%
8,150,000
+7,241,400
+797% +$59.9M

Similar funds

Rubric Capital Management (New York)'s Q2 2024 Portfolio in Review

As of Q2 2024, Rubric Capital Management (New York) held 75 positions worth $3.81B, up 13% from $3.38B the previous quarter. Its ten largest holdings account for 44% of the portfolio.

Rubric Capital Management (New York) deployed $532M of net new capital in Q2 2024, opening 7 new positions and adding to 31 existing holdings. Its largest new stake was Alight: 421,153 shares worth $62.2M.

By sector, the portfolio is most concentrated in Healthcare at 50% of assets, up from 48% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was Playa Hotels & Resorts, an estimated $27.5M trimmed.

  • Rubric Capital Management (New York)'s largest Q2 2024 buy was Alight: 421,153 shares worth $62.2M.
  • Rubric Capital Management (New York) added most to Pediatrix Medical in Q2 2024, an estimated $59.9M increase.
  • Rubric Capital Management (New York)'s biggest Q2 2024 reduction was Playa Hotels & Resorts, cutting an estimated $27.5M.
  • Rubric Capital Management (New York) fully exited iShares Bitcoin Trust in Q2 2024, selling an estimated $69.7M.
  • Rubric Capital Management (New York)'s ten largest holdings make up 44% of its $3.81B portfolio in Q2 2024.
  • Rubric Capital Management (New York) opened 7 new positions and closed 7 in Q2 2024.
  • Rubric Capital Management (New York)'s portfolio value rose 13% quarter-over-quarter to $3.81B.

Based on Rubric Capital Management (New York)'s 13F filing for Q2 2024, filed 13 Aug 2024.